Researchers are reporting some encouraging news on the HIV prevention front: Preliminary tests have found no safety problems with a vaginal gel designed to keep the AIDS virus at bay during intercourse. The findings are published in the February 28th issue of the journal AIDS.

Researchers found the microbicide vaginal gel tenofovir produced mild or no side effects in both HIV positive and HIV negative women. Tenofovir is the active ingredient in the anti-retroviral drug Viread

The U.S. government stopped a trial of AIDS drugs Wednesday aimed at finding out if patients could take breaks from treatment. It said people were more likely to become ill or die if they took breaks.

The National Institute of Allergy and Infectious Diseases (NIAID) says the trial was quick to show patients fare better when they continuously take the drugs

A gay couple in the U.K. are taking the government to court to gain access to a "morning after pill" for HIV.

They want greater public access to the post-exposure prophylaxis (PEP) drug, which is currently most often given to health workers who are accidentally exposed, or for rape victims

More than 250 East African children are receiving life-sustaining AIDS therapy as a result of an innovative program from Compassion International.

Dr. Scott Todd, Director of Compassion's AIDS Initiative says, "There is no doubt these children would have died without these treatments

Activists and doctors are suing to try and force South Africa's health minister to shut down a doctor who allegedly pushed AIDS patients to take vitamin compounds instead of antiretroviral therapy.

The Treatment Action Campaign says German born Matthias Rush endangered AIDS patients by advocating vitamin compounds as an alternative therapy